(Q52579142)

3 May 2018

editorial

0 references

title

Cell adhesion and cancer: is there a potential for therapeutic intervention? (English)

1 reference

3 May 2018

1 reference

Robert M Lafrenie

1

1 reference

3 May 2018

Carly A Buckner

series ordinal

2

1 reference

3 May 2018

Mary A Bewick

series ordinal

3

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

3 May 2018

Expert Opinion on Therapeutic Targets

published in

1 reference

3 May 2018

volume

11

1 reference

3 May 2018

issue

6

1 reference

3 May 2018

page(s)

727-731

1 reference

3 May 2018

Cell adhesion molecules, signal transduction and cell growth

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Endothelial cell adhesion molecules and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Integrins: regulators of tissue function and cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Yos9p detects and targets misfolded glycoproteins for ER-associated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphav-mediated proliferation of SK-Mel-2 human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Antiangiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.727

10.1517/14728222.11.6.727

21 January 2018

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018